NanoVibronix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NanoVibronix and buy or sell other stocks, ETFs, and their options commission-free!About NAOV
ENvue Medical, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield.
CEODoron Robert Besser, MD
CEODoron Robert Besser, MD
Employees31
Employees31
HeadquartersTyler, Texas
HeadquartersTyler, Texas
Founded2003
Founded2003
Employees31
Employees31
NAOV Key Statistics
Market cap6.32M
Market cap6.32M
Price-Earnings ratio-0.03
Price-Earnings ratio-0.03
Dividend yield—
Dividend yield—
Average volume21.77K
Average volume21.77K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$162.50
52 Week high$162.50
52 Week low$2.75
52 Week low$2.75
Stock Snapshot
As of today, NanoVibronix(NAOV) shares are valued at $6.25. The company's market cap stands at 6.32M, with a P/E ratio of -0.03.
On 2025-12-25, NanoVibronix(NAOV) stock opened at —, reached a high of —, and a low of —.
The NanoVibronix(NAOV)'s current trading volume is 0, compared to an average daily volume of 21.77K.
In the last year, NanoVibronix(NAOV) shares hit a 52-week high of $162.50 and a 52-week low of $2.75.
In the last year, NanoVibronix(NAOV) shares hit a 52-week high of $162.50 and a 52-week low of $2.75.
People also own
Based on the portfolios of people who own NAOV. This list is generated using Robinhood data, and it’s not a recommendation.